PBA
OYST
Paradigm Biocapital Advisors’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,648,316
| Closed | -$9.26M | – | 30 |
|
|
2022
Q3 | $9.26M | Buy |
1,648,316
+314,986
| +24% | +$1.77M | 1.24% | 23 |
|
|
2022
Q2 | $5.77M | Buy |
1,333,330
+345,632
| +35% | +$1.5M | 1.15% | 20 |
|
|
2022
Q1 | $11.5M | Buy |
987,698
+683,460
| +225% | +$7.96M | 3.04% | 16 |
|
|
2021
Q4 | $5.56M | Buy |
+304,238
| New | +$5.56M | 1.59% | 21 |
|